Designing Visfatin Inhibitors to Limit Its Insulin Mimcy and Type II Diabetes.

doi 10.3390/ecsoc-17-e018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI

Related search

Changes in Plasma Visfatin and Insulin Resistance Index in Obese Women With Type 2 Diabetes After Pilates Exercise

Journal of Health and Care
2018English

Timing of Meal Insulin and Its Relation to Adherence to Therapy in Type 1 Diabetes

Journal of diabetes science and technology
Internal MedicineEndocrinologyBioengineeringBiomedical EngineeringMetabolismDiabetes
2017English

PDH Kinase Inhibitors: A Novel Therapy for Type II Diabetes?

Biochemical Society Transactions
Biochemistry
2005English

Asymptomatic Bacteriuria and Its Associated Factors in Type II Diabetes Mellitus

International Journal of Advances in Medicine
2017English

Insulin Gene Polymorphisms in Type 1 Diabetes, Addison's Disease and the Polyglandular Autoimmune Syndrome Type II

BMC Medical Genetics
Genetics
2008English

Insulin Glargine/Lixisenatide in Type 2 Diabetes: A Profile of Its Use

Drugs and Therapy Perspectives
Pharmacology
2019English

Effect of Caffeine on Plasma Glucose and Insulin Response to Mixed Meal Tolerance Test in Type II Diabetes

Medicine Today
2012English

Type–ii Diabetes Mellitus;

The Professional Medical Journal
2019English

Insulin Treatment and Type 1 Diabetes Topics

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy